The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment
- PMID: 16503210
- DOI: 10.1016/j.bone.2006.01.142
The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment
Abstract
Glucocorticoids (GC) are used for the treatment of a wide spectrum of diseases because of their potent anti-inflammatory and immunosuppressive effects, and they are serious and common causes of secondary osteoporosis. Administration of intermittent parathyroid hormone (PTH) may induce formation of new bone and may counteract the bone loss induced by GC treatment. Effects of simultaneous PTH and GC treatment were investigated on bone biomechanics, static and dynamic histomorphometry, and bone metabolism. Twenty-seven-month-old female rats were divided randomly into the following groups: baseline, vehicle, PTH, GC, and PTH + GC. PTH (1-34) 25 mug/kg and GC (methylprednisolone) 2.5 mg/kg were injected subcutaneously each day for a treatment period of 8 weeks. The rats were labeled with fluorochromes 3 times during the experiment. Bone sections were studied by fluorescence microscopy. The PTH injections resulted in a 5-fold increase in cancellous bone volume. At the proximal tibia, PTH induced a pronounced formation of new cancellous bone which originated from the endocortical bone surfaces and from thin trabeculae. Formation and modeling of connections between trabeculae were observed. Similar but less pronounced structural changes were seen in the PTH + GC group. The compressive strength of the cancellous bone was increased by 6-fold in the PTH group compared with the vehicle group. GC partially inhibited the increase in compressive strength induced by PTH. Concerning cortical bone, PTH induced a pronounced increase in the endocortical bone formation rate (BFR) and a smaller increase in periosteal BFR. The combination of PTH + GC resulted in a partial inhibition of the PTH-induced increase in bone formation. Serum-osteocalcin was increased by 65% in the PTH group and reduced by 39% in the GC group. The pronounced anabolic effect of PTH injections on the endocortical and trabecular bone surfaces and less pronounced anabolic effect on periosteal surfaces were partially inhibited, but not prevented, by simultaneous GC treatment in old rats. Both cortical and cancellous bone possessed full mechanical competence after treatment with PTH + GC.
Similar articles
-
Parathyroid hormone and mechanical usage have a synergistic effect in rat tibial diaphyseal cortical bone.J Bone Miner Res. 1999 Mar;14(3):439-48. doi: 10.1359/jbmr.1999.14.3.439. J Bone Miner Res. 1999. PMID: 10027909
-
Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits.J Bone Miner Res. 1999 Apr;14(4):536-45. doi: 10.1359/jbmr.1999.14.4.536. J Bone Miner Res. 1999. PMID: 10234574
-
Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats.J Bone Miner Res. 1996 Apr;11(4):421-9. doi: 10.1002/jbmr.5650110402. J Bone Miner Res. 1996. PMID: 8992872
-
Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure.Bone. 2007 Jun;40(6):1447-52. doi: 10.1016/j.bone.2006.09.008. Epub 2006 Oct 12. Bone. 2007. PMID: 17045858 Review.
-
The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.APMIS Suppl. 2001;(102):1-52. APMIS Suppl. 2001. PMID: 11419022 Review.
Cited by
-
Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice.Endocrinology. 2010 Jun;151(6):2641-9. doi: 10.1210/en.2009-1488. Epub 2010 Apr 21. Endocrinology. 2010. PMID: 20410195 Free PMC article.
-
Evolutionary medicine and bone loss in chronic inflammatory diseases--A theory of inflammation-related osteopenia.Semin Arthritis Rheum. 2015 Oct;45(2):220-8. doi: 10.1016/j.semarthrit.2015.04.014. Epub 2015 Apr 30. Semin Arthritis Rheum. 2015. PMID: 26044543 Free PMC article. Review.
-
Management of glucocorticoid-induced osteoporosis.Nat Rev Rheumatol. 2010 Feb;6(2):82-8. doi: 10.1038/nrrheum.2009.259. Nat Rev Rheumatol. 2010. PMID: 20125175 Review.
-
Short-term glucocorticoid excess blunts abaloparatide-induced increase in femoral bone mass and strength in mice.Sci Rep. 2021 Jun 10;11(1):12258. doi: 10.1038/s41598-021-91729-8. Sci Rep. 2021. PMID: 34112892 Free PMC article.
-
Improvement of trochanteric bone quality in an osteoporosis model after short-term treatment with parathyroid hormone: a new mechanical test for trochanteric region of rat femur.Osteoporos Int. 2010 Feb;21(2):251-61. doi: 10.1007/s00198-009-0941-y. Epub 2009 May 13. Osteoporos Int. 2010. PMID: 19436940 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous